For Immediate Release
International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Their Official Journal
Contact: Kathryn Ryan
New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is pleased to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international society spearheading scientific research in all fields of cannabinoids, ranging from biochemical, chemical, and physiological studies of the endogenous cannabinoid system to studies on the misuse potential of recreational cannabis. In addition to being a leading source for unbiased information on cannabis and cannabinoids, the main role of the ICRS is to provide an essential forum for researchers to meet and discuss their scientific goals, aspirations, and achievements and for dissemination of evidence-based information on the endocannabinoid system. This collaboration between the ICRS and Cannabis and Cannabinoid Research is one that will not only benefit the scientific reach of cannabis, cannabinoids, and the endocannabinoid system, but will also greatly benefit this community of international researchers.
“On behalf of the ICRS, I am delighted to announce our new publishing partner in Cannabis and Cannabinoid Research. As a prestigious and well-respected journal in our field, with outstanding leadership and a stellar editorial board of accomplished researchers, I am confident that our members will benefit greatly from this partnership and, together with the ICRS Board of Directors and Members, I look forward to advancing our research goals together in the coming years,” says Heather Bradshaw, PhD, Past-President and Executive Member of the ICRS Board.
“We are honored that ICRS, the longest-standing learned society dedicated to cannabinoid science, has selected Cannabis and Cannabinoid Research as its Official Journal,” says Daniele Piomelli, PhD, PharmD, Editor-in-Chief of CCR. “The membership of ICRS is at the forefront of research on cannabis, cannabinoids and the endocannabinoid system. Our journal shares this ideal and is delighted to work by their side.”
Dr. Piomelli and the leadership of Cannabis and Cannabinoid Research look forward to working even more closely with international cannabis and cannabinoid research experts to enhance ICRS and its mission, the Journal, and the field.
Cannabis and Cannabinoid Research also works in collaboration with the International Association for Cannabinoid Medicines (IACM) and Fundación CANNA.
About the Journal
Cannabis and Cannabinoid Research is the premier journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Cannabis and Cannabinoid Research is indexed in leading databases such as PubMed Central, EMBASE/Excerpta Medica, Scopus, and ProQuest.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including The Journal of Alternative and Complementary Medicine, Journal of Caffeine and Adenosine Research, Journal of Child and Adolescent Psychopharmacology, and Journal of Palliative Medicine. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's more than 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.